Dan Liao

7PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsOncology and carcinogenesis not elsewhere classifiedSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 07, 2026
METTL3-mediated m6A modification of FDX1 confers resistance to cuproptosis and promotes hepatocellular carcinoma progression.

Qian Jiang, Chen Peng, Wenhao Mao

|Feb 05, 2024
Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.

Dan Liao, Li Zhong, Junqiang Yin

|Nov 22, 2023
Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma.

Li Zhong, Jingxuan Wang, Wanqi Chen

|Aug 11, 2023
CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancer.

Wenqiang Liu, Ruhua Zhang, Xinhao Yu

|Dec 18, 2022
Targeting the Lysosomal Degradation of Rab22a-NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis.

Cuiling Zeng, Li Zhong, Wenqiang Liu

|Jun 13, 2020
Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.

Dan Liao, Li Zhong, Junqiang Yin

Pageof 2

Frequent Collaborators

4 joint publications

Li Zhong

4 joint publications

Junqiang Yin

4 joint publications

Tiebang Kang

3 joint publications

Cuiling Zeng